Anavex Life Sciences Corp (AVXL)

[sokol]

“Uncertainty is the only certainty there is, and knowing how to live with insecurity is the only security.”
? John Allen Paulos

Any new, innovative idea is fraught with uncertainty, takes time and has to go through the stage of looking wrong because it involves doing something that no one else has done. Our drug, AVXL 2-73, is based on new science for treating Alzheimer’s and other CNS diseases. Additionally, the pending clinical trials and FDA guidelines are new.


As traders and investors we must do our utmost to suppress our emotions. When you approach a market with emotion, you are doing yourself an immense disservice. Many posters here are frustrated with the price action. I understand where it is coming from; however, I urge you to try to suppress your frustration until we know something for sure. We should not let emotions and frustrations get the best of us if we have done the due diligence that convinced us to invest in this new science. If we feel we are right, we should put our emotions aside and sit tight.

So far, I do not see that anything has changed except for the share price.

As someone said: ”Anavex was launched with a drug that targets the Sigma-1 receptor to activate cellular autophagy or digestion of misfolded proteins. The Sigma-1 receptor is an important therapeutic target. The Anavex drugs have, pre-clinically, proven effective in various central nervous system disorders, including Alzheimer’s, Rett syndrome, Parkinson’s disease, and depression. This technology has applications for anti-aging therapies as well as age-related and genetic diseases.” Has any of this changed? I do not think so. This is why I purchased my Anavex shares, and why I will not allow my frustration, impatience and emotions convince me to dump my shares.